Literature DB >> 11796955

Determinants and consequences of post-stroke depression.

Guido Gainotti1, Camillo Marra.   

Abstract

Post-stroke depression (PSD) is a very frequent and important consequence of stroke, but, in spite of the high number of papers aiming to clarify various aspects of this disorder, controversies about its incidence, its (biological or psychological) determinants, its consequences and its treatment still persist. In the present survey we have taken separately into account each of these issues, starting from a critical discussion of the main factors which can affect the estimates of the incidence of PSD. We have then surveyed and updated the debate between proponents of a neuroanatomical and a psychological interpretation of PSD. Our conclusions have been that the most recent evidence does not support Robinson's influential neuroanatomical model, assuming that a left frontal stroke could provoke a major PSD, indistinguishable from the functional forms of major depression. In the section devoted to the consequences of PSD, we have particularly taken into account the problem of the deleterious influence that PSD could have on functional recovery. The available evidence does not allow us to conclude if an improvement of PSD also leads to an improvement of the patient's functional status. As for the therapy of PSD, a pharmacological treatment with selective serotonin reuptake inhibitors has proven effective and safe, whereas psychological methods of treatment of patients and their families have not yet given conclusive results.

Entities:  

Mesh:

Year:  2002        PMID: 11796955     DOI: 10.1097/00019052-200202000-00013

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  10 in total

Review 1.  Rose-colored answers: neuropsychological deficits and patient-reported outcomes after stroke.

Authors:  Anna M Barrett
Journal:  Behav Neurol       Date:  2010       Impact factor: 3.342

2.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

3.  A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD).

Authors:  Xinghua Ding; Ruoxu Liu; Wenkai Li; Hengjia Ni; Yong Liu; Dandan Wu; Shuguang Yang; Jing Liu; Bo Xiao; Shaojun Liu
Journal:  Metab Brain Dis       Date:  2015-11-05       Impact factor: 3.584

4.  Patients with severe poststroke fatigue show a psychosocial profile comparable to patients with other chronic disease: implications for diagnosis and treatment.

Authors:  Aglaia M E E Zedlitz; Anne J M A Visser-Meily; Vera P Schepers; Alexander C H Geurts; Luciano Fasotti
Journal:  ISRN Neurol       Date:  2011-11-09

5.  Post stroke depression.

Authors:  Azra Alajbegovic; Jasminka Djelilovic-Vranic; Amina Nakicevic; Ljubica Todorovic; Merita Tiric-Campara
Journal:  Med Arch       Date:  2014

Review 6.  Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms.

Authors:  Jong S Kim
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

Review 7.  Risk Factors for Post-stroke Depression: A Meta-analysis.

Authors:  Yu Shi; Dongdong Yang; Yanyan Zeng; Wen Wu
Journal:  Front Aging Neurosci       Date:  2017-07-11       Impact factor: 5.750

8.  Health-related quality of life of patients six months poststroke living in the Western Cape, South Africa.

Authors:  Anthea J Rhoda
Journal:  Afr J Disabil       Date:  2014-11-21

9.  Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis.

Authors:  Sahar Dalvand; Reza Ghanei Gheshlagh; Amanj Kurdi
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-13       Impact factor: 2.570

10.  Burden of depression and predictors among Ethiopian stroke survivors: Cross-sectional study.

Authors:  Ashenafi Zemed; Kedir Sany; Moges Gahaw
Journal:  Ann Med Surg (Lond)       Date:  2021-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.